• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Liposomes, lipid A, and aluminum hydroxide enhance the immune response to a synthetic malaria sporozoite antigen.脂质体、脂多糖A和氢氧化铝可增强对合成疟原虫子孢子抗原的免疫反应。
Infect Immun. 1988 Mar;56(3):682-6. doi: 10.1128/iai.56.3.682-686.1988.
2
Immunogenicity of liposomal malaria sporozoite antigen in monkeys: adjuvant effects of aluminium hydroxide and non-pyrogenic liposomal lipid A.
Vaccine. 1989 Dec;7(6):506-12. doi: 10.1016/0264-410x(89)90274-0.
3
Liposomes containing lipid A: a potent nontoxic adjuvant for a human malaria sporozoite vaccine.含脂质A的脂质体:一种用于人类疟疾子孢子疫苗的高效无毒佐剂。
Immunol Lett. 1990 Aug;25(1-3):275-9. doi: 10.1016/0165-2478(90)90127-c.
4
Plasmodium falciparum: immunogenicity of circumsporozoite protein constructs produced in Escherichia coli.恶性疟原虫:大肠杆菌中产生的环子孢子蛋白构建体的免疫原性
Exp Parasitol. 1987 Apr;63(2):166-72. doi: 10.1016/0014-4894(87)90158-5.
5
Liposomes containing lipid A serve as an adjuvant for induction of antibody and cytotoxic T-cell responses against RTS,S malaria antigen.含有脂多糖A的脂质体可作为佐剂,用于诱导针对RTS,S疟疾抗原的抗体和细胞毒性T细胞反应。
Infect Immun. 1998 Jun;66(6):2859-65. doi: 10.1128/IAI.66.6.2859-2865.1998.
6
Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum.对疟疾的免疫力以及对恶性疟原虫环子孢子蛋白的自然获得性抗体。
N Engl J Med. 1986 Sep 4;315(10):601-6. doi: 10.1056/NEJM198609043151001.
7
Synthetic low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund complete adjuvant in inducing growth-inhibitory antibodies to the Plasmodium falciparum major merozoite surface protein, gp195.合成的低毒性胞壁酰二肽和单磷酰脂质A在诱导针对恶性疟原虫主要裂殖子表面蛋白gp195的生长抑制性抗体方面可替代弗氏完全佐剂。
Infect Immun. 1991 May;59(5):1585-91. doi: 10.1128/iai.59.5.1585-1591.1991.
8
Effectiveness of liposomes as potential carriers of vaccines: applications to cholera toxin and human malaria sporozoite antigen.脂质体作为疫苗潜在载体的有效性:在霍乱毒素和人类疟原虫孢子体抗原中的应用。
Vaccine. 1986 Sep;4(3):166-72. doi: 10.1016/0264-410x(86)90005-8.
9
Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy.人用脂质体疟疾疫苗:一种安全有效的佐剂策略。
Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):358-62. doi: 10.1073/pnas.89.1.358.
10
Comparison of antibody responses to the circumsporozoite protein repeat region and to intact sporozoites during acute falciparum malaria.急性恶性疟期间针对环子孢子蛋白重复区域和完整子孢子的抗体反应比较。
Trans R Soc Trop Med Hyg. 1989 Mar-Apr;83(2):154-7. doi: 10.1016/0035-9203(89)90623-8.

引用本文的文献

1
Safety and Toxicology Profile of TT-6-AmHap Heroin Conjugate Vaccine.TT-6-AmHap 海洛因结合疫苗的安全性和毒理学概况
Vaccines (Basel). 2025 Jul 26;13(8):792. doi: 10.3390/vaccines13080792.
2
Enhancing encapsulation of filarial antigen thioredoxin in nano-liposomes: The role of lecithin composition.增强丝状抗原硫氧还蛋白在纳米脂质体中的包封:卵磷脂组成的作用。
ADMET DMPK. 2023 Nov 30;12(2):379-389. doi: 10.5599/admet.2089. eCollection 2024.
3
Vaccine approaches for antigen capture by liposomes.脂质体抗原捕获的疫苗方法。
Expert Rev Vaccines. 2023 Jan-Dec;22(1):1022-1040. doi: 10.1080/14760584.2023.2274479. Epub 2023 Nov 6.
4
Liposomes for malaria management: the evolution from 1980 to 2020.脂质体用于疟疾管理:1980 年至 2020 年的发展历程。
Malar J. 2021 Jul 27;20(1):327. doi: 10.1186/s12936-021-03858-0.
5
Plasmodium falciparum pre-erythrocytic stage vaccine development.恶性疟原虫红前期疫苗的研制。
Malar J. 2020 Feb 3;19(1):56. doi: 10.1186/s12936-020-3141-z.
6
Induction of Plasmodium-Specific Immune Responses Using Liposome-Based Vaccines.利用脂质体疫苗诱导疟原虫特异性免疫应答。
Front Immunol. 2019 Feb 1;10:135. doi: 10.3389/fimmu.2019.00135. eCollection 2019.
7
Suppression of established hepatocarcinoma in adjuvant only immunotherapy: alum triggers anti-tumor CD8+ T cell response.仅辅助免疫疗法对已建立的肝癌的抑制作用:明矾引发抗肿瘤CD8 + T细胞反应。
Sci Rep. 2015 Dec 9;5:17695. doi: 10.1038/srep17695.
8
The Use of Synthetic Carriers in Malaria Vaccine Design.合成载体在疟疾疫苗设计中的应用。
Vaccines (Basel). 2015 Oct 29;3(4):894-929. doi: 10.3390/vaccines3040894.
9
All-trans retinoic acid potentiates the antibody response in mice to a lipopeptide antigen adjuvanted with liposomal lipid A.全反式维 A 酸增强了脂肽抗原与脂质 A 脂质体佐剂在小鼠中的抗体应答。
Immunol Cell Biol. 2009 Nov-Dec;87(8):630-3. doi: 10.1038/icb.2009.48. Epub 2009 Jul 14.
10
Influenza vaccines. A reappraisal of their use.流感疫苗。对其使用的重新评估。
Drugs. 1997 Dec;54(6):841-56. doi: 10.2165/00003495-199754060-00004.

本文引用的文献

1
Effects of lipid A and liposomes containing lipid A on platelet and fibrinogen production in rabbits.
Blood. 1980 Aug;56(2):307-10.
2
Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax.人类疟原虫恶性疟原虫和间日疟原虫的环子孢子蛋白。
J Exp Med. 1982 Jul 1;156(1):20-30. doi: 10.1084/jem.156.1.20.
3
Humoral and cellular immunity to hepatitis B virus-derived antigens: comparative activity of Freund complete adjuvant alum, and liposomes.针对乙肝病毒衍生抗原的体液免疫和细胞免疫:弗氏完全佐剂、明矾和脂质体的比较活性。
Infect Immun. 1980 Dec;30(3):728-33. doi: 10.1128/iai.30.3.728-733.1980.
4
Vaccine adjuvants.疫苗佐剂。
Rev Infect Dis. 1980 May-Jun;2(3):370-83. doi: 10.1093/clinids/2.3.370.
5
Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection.针对子孢子表面抗原(Pb44)的单克隆抗体的单价片段(Fab)可保护小鼠免受疟疾感染。
J Exp Med. 1980 Jun 1;151(6):1504-13. doi: 10.1084/jem.151.6.1504.
6
Endotoxin enhanced adjuvant effect of liposomes, particularly when antigen and endotoxin are incorporated within the same liposome.内毒素增强了脂质体的佐剂效应,尤其是当抗原和内毒素被包裹在同一脂质体内时。
Immunol Commun. 1980;9(8):747-57. doi: 10.3109/08820138009109684.
7
Interactions of lipid a and liposome-associated lipid A with Limulus polyphemus amoebocytes.脂多糖A和脂质体相关脂多糖A与鲎变形细胞的相互作用。
Infect Immun. 1983 Mar;39(3):1385-91. doi: 10.1128/iai.39.3.1385-1391.1983.
8
Sporozoites of mammalian malaria: attachment to, interiorization and fate within macrophages.哺乳动物疟疾的子孢子:在巨噬细胞内的附着、内化及归宿
J Protozool. 1980 May;27(2):193-202. doi: 10.1111/j.1550-7408.1980.tb04680.x.
9
Phase-I study of intravenous modified lipid A.静脉注射修饰脂质A的I期研究。
Cancer Immunol Immunother. 1984;18(2):107-12. doi: 10.1007/BF00205743.
10
Comparative immunogenicity studies on Epstein-Barr virus membrane antigen (MA) gp340 with novel adjuvants in mice, rabbits, and cotton-top tamarins.
J Med Virol. 1984;13(3):281-92. doi: 10.1002/jmv.1890130310.

脂质体、脂多糖A和氢氧化铝可增强对合成疟原虫子孢子抗原的免疫反应。

Liposomes, lipid A, and aluminum hydroxide enhance the immune response to a synthetic malaria sporozoite antigen.

作者信息

Richards R L, Hayre M D, Hockmeyer W T, Alving C R

机构信息

Department of Membrane Biochemistry, Walter Reed Army Institute of Research, Washington, D.C. 20307-5100.

出版信息

Infect Immun. 1988 Mar;56(3):682-6. doi: 10.1128/iai.56.3.682-686.1988.

DOI:10.1128/iai.56.3.682-686.1988
PMID:3277918
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC259345/
Abstract

A liposome-encapsulated cloned protein (R32tet32) containing sequences from the tetrapeptide repeat region of the circumsporozoite protein of Plasmodium falciparum sporozoites was examined for immunogenicity with rabbits and monkeys. Effects of adjuvants were tested by encapsulation of the antigen in liposomes either lacking or containing lipid A and adsorption with aluminum hydroxide (ALUM). When rabbits were immunized with R32tet32 alone, a primary antibody response was not seen and a secondary response did not appear until 32 to 36 weeks after boosting. Immunization with ALUM-adsorbed R32tet32 resulted in a minimal primary antibody response. A moderate secondary antibody response was detected within 2 weeks after boosting, but antibody levels decreased to preimmunization levels 8 weeks after boosting. When R32tet32 was encapsulated in liposomes containing lipid A, strong primary and secondary antibody responses were observed. Strong primary and secondary responses also were obtained when R32tet32 was encapsulated in liposomes either containing or lacking lipid A and the liposomes were adsorbed with ALUM. The strongest antibody response was obtained by immunization with ALUM-adsorbed liposomes containing lipid A and R32tet32, suggesting that the adjuvant effects of liposomes, lipid A, and ALUM were additive or synergistic.

摘要

对一种脂质体包裹的克隆蛋白(R32tet32)进行了研究,该蛋白含有恶性疟原虫子孢子环子孢子蛋白四肽重复区域的序列,用兔子和猴子检测其免疫原性。通过将抗原包裹在不含或含有脂多糖A的脂质体中以及用氢氧化铝(ALUM)吸附来测试佐剂的效果。当单独用R32tet32免疫兔子时,未观察到初次抗体反应,直到加强免疫后32至36周才出现二次反应。用ALUM吸附的R32tet32免疫产生的初次抗体反应极小。加强免疫后2周内检测到中等程度的二次抗体反应,但加强免疫8周后抗体水平降至免疫前水平。当R32tet32包裹在含有脂多糖A的脂质体中时,观察到强烈的初次和二次抗体反应。当R32tet32包裹在含或不含脂多糖A的脂质体中且脂质体用ALUM吸附时,也获得了强烈的初次和二次反应。通过用含脂多糖A和R32tet32的ALUM吸附脂质体免疫获得了最强的抗体反应,表明脂质体、脂多糖A和ALUM的佐剂作用是相加或协同的。